Skip to main content
. 2013 May 25;13:259. doi: 10.1186/1471-2407-13-259

Table 5.

Correlation between RASSF1A protein expression and clinicopathological parameters of ESCC and GCA patients

Classification ESCC (n=27)
 GCA (n=24)
N
 Positive
 Negative
 P OR(95%CI) N
 Positive
 Negative
 P OR(95%CI)
n (%) n (%) n (%) n (%) n (%) n (%)
Gender
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 Male
 18
 (67)
 10
 (56)
 8
 (44)
  
  
 14
 (58)
 6
 (43)
 8
 (57)
  
  
 
 Female
 9
 (33)
 7
 (78)
 2
 (22)
 0.27
 0.36(0.06–2.22)
 10
 (42)
 8
 (80)
 2
 (20)
 0.08
 0.19(0.03–1.23)
Age(y)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 ≤40
 12
 (44)
 10
 (83)
 2
 (17)
  
  
 10
 (42)
 9
 (90)
 1
 (10)
  
  
 
 ≥70
 15
 (56)
 7
 (47)
 8
 (53)
 0.06
 5.71(0.92–35.48)
 14
 (58)
 5
 (36)
 9
 (64)
 0.02
 16.20(1.57–167.74)
Differentiation classification
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 High+Middle
 23
 (85)
 13
 (57)
 10
 (43)
  
  
 14
 (58)
 6
 (43)
 8
 (57)
  
  
 
 Low
 4
 (15)
 4
 (100)
 0
 (0)
 0.10
  
 10
 (42)
 8
 (80)
 2
 (20)
 0.08
 0.19(0.03–1.23)
Tumor stage (T) classification
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 T1+T2
 6
 (22)
 4
 (67)
 2
 (33)
  
  
 2
 (8)
 1
 (50)
 1
 (50)
  
  
 
 T3+T4
 21
 (78)
 13
 (62)
 8
 (38)
 0.57
 1.88(0.22–15.93)
 22
 (92)
 13
 (59)
 9
 (41)
 0.73
 0.75(0.15–3.83)
Tumor stage (N) classification
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 N0
 20
 (74)
 13
 (65)
 7
 (35)
  
  
 15
 (63)
 9
 (60)
 6
 (40)
  
  
 
 N1
 7
 (26)
 4
 (57)
 3
 (43)
 0.41
 2.18(0.35–13.76)
 9
 (38)
 5
 (56)
 4
 (44)
 0.83
 0.83(0.16–4.44)
Tumor stage (TNM) classification
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 I+II
 20
 (74)
 12
 (60)
 8
 (40)
  
  
 21
 (88)
 12
 (57)
 9
 (43)
  
  
  III+IV 7 (26) 5 (71) 2 (29) 0.59 1.67(0.26–10.79) 3 (13) 2 (67) 1 (33) 0.76 1.50(0.12–19.24)